Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001593968-20-000621)

Filing Details

Accession Number:: 0001593968-20-000621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-04 16:35:52
Reporting Period:: 2020-03-02

Accepted Time:: 2020-03-04 16:35:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	Pharmaceutical Preparations (2834)	270605902

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777760	Craig Andrew Miller	33 Arch St Ste 3110 Boston MA 02110-1424	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-02	17,857	$2.92	17,857	No	4	M	Direct
Common Stock	Disposition	2020-03-02	17,857	$86.61	0	No	4	S	Direct
Common Stock	Acquisiton	2020-03-02	7,143	$2.92	7,143	No	4	M	Direct
Common Stock	Disposition	2020-03-02	7,143	$86.61	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Karuna Therapeutics, Inc. Common Stock	Option (right to buy)	Disposition	2020-03-02	17,857	$0.00	17,857	$2.92
Karuna Therapeutics, Inc. Common Stock	Option (right to buy)	Disposition	2020-03-02	7,143	$0.00	7,143	$2.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-05-31	2026-05-31	No	4	M	Direct
153,571	2016-07-18	2026-10-12	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.